The present invention provides a process for preparing 2-methyl-N-(2′-methylbutyl)butanamide of the following formula (1):the process comprising: subjecting an α-arylethyl-2-methylbutylamine compound of the following general formula (2): wherein Ar represents a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, to N-2-methylbutyrylation to form an N-α-arylethyl-2-methyl-N-(2′-methylbutyl)butanamide compound of the following general formula (3): wherein Ar is as defined above, and removing the α-arylethyl group of the resulting compound (3) to form 2-methyl-N-(2′-methylbutyl)butanamide (1).

##STR00001##

Surfactant compositions and derivatives with low amounts of impurities are disclosed along with a method of making the same. A surfactant composition includes greater than 80% by weight of N-acyl amino acid surfactant of formula (I) and is substantially free of solvents and/or NaCl. A process for preparing an N-acyl amino acid surfactant includes combining an amino acid, a waterless base and a fatty alkyl ester of formula (III) to form a mixture that includes an amino acid salt of formula (II). The temperature of the mixture is increased to form a reaction mixture. Alkyl alcohol is removed from the reaction mixture, and the reaction mixture becomes substantially clear.

Surfactant compositions and derivatives with low amounts of impurities are disclosed along with a method of making the same. A surfactant composition includes greater than 80% by weight of N-acyl amino acid surfactant of formula (I) and is substantially free of solvents and/or NaCl. A process for preparing an N-acyl amino acid surfactant includes combining an amino acid, a waterless base and a fatty alkyl ester of formula (III) to form a mixture that includes an amino acid salt of formula (II). The temperature of the mixture is increased to form a reaction mixture. Alkyl alcohol is removed from the reaction mixture, and the reaction mixture becomes substantially clear.

Polyamide and amidoamine curing agents comprising a selectively modified amine. The selectively modified amine is formed by a substitution reaction between a polyamine and an epoxide, resulting in a multifunctional amine having a hydroxyl substituent. The curing agents are used to form epoxy resins having improved properties when cured.

Polyamide and amidoamine curing agents comprising a selectively modified amine. The selectively modified amine is formed by a substitution reaction between a polyamine and an epoxide, resulting in a multifunctional amine having a hydroxyl substituent. The curing agents are used to form epoxy resins having improved properties when cured.

Provided is a process for the preparation of certain 1,4-bicyclo[2.2.2]octane derivatives. The new synthetic procedure involves treating 1,4-dimethylene cyclohexane with an oxidizing agent in the presence of a transition metal catalyst to afford an oxo-substituted bicyclo[2.2.2]octane species. This intermediate structure can then be further derivatized. The processes of this disclosure thus affords a novel and simplified means for the commercial production of a wide variety of bicyclo[2.2.2]octane derivatives.

Provided is a process for the preparation of certain 1,4-bicyclo[2.2.2]octane derivatives. The new synthetic procedure involves treating 1,4-dimethylene cyclohexane with an oxidizing agent in the presence of a transition metal catalyst to afford an oxo-substituted bicyclo[2.2.2]octane species. This intermediate structure can then be further derivatized. The processes of this disclosure thus affords a novel and simplified means for the commercial production of a wide variety of bicyclo[2.2.2]octane derivatives.

A composition of acylethanolamides is obtained from olive oil fatty acids and is used in treating neuroinflammation. The acylethanolamide complex includes (weight percentages):

TABLE-US-00001 oleoylethanolamide (OEA) C18:1 60-65%  palmitoylethanolamide (PEA) C16:0 5-20% linoleylethanolamide (LEA) C18:2 5-20% stearoylethanolamide (SEA) C18:0  1-2% palmitoylethanolamide (POEA) C16:1 0.1-0.8%  myristoylethanolamide (MEA) C14:0 0.02-0.15%   mixture of glycerides  4-6% glycerol .sup. 6-8%.

A method obtains the acylethanolamide complex and formulations contain the acylethanolamide complex.

A composition of acylethanolamides is obtained from olive oil fatty acids and is used in treating neuroinflammation. The acylethanolamide complex includes (weight percentages):

TABLE-US-00001 oleoylethanolamide (OEA) C18:1 60-65%  palmitoylethanolamide (PEA) C16:0 5-20% linoleylethanolamide (LEA) C18:2 5-20% stearoylethanolamide (SEA) C18:0  1-2% palmitoylethanolamide (POEA) C16:1 0.1-0.8%  myristoylethanolamide (MEA) C14:0 0.02-0.15%   mixture of glycerides  4-6% glycerol .sup. 6-8%.

A method obtains the acylethanolamide complex and formulations contain the acylethanolamide complex.

The invention concerns synthesized amido-amine-based cationic gemini surfactants with flexible and rigid spacers and different hydrophobic. These gemini surfactants were prepared by modified procedure through amidation of long chain carboxylic acids using 3-(dimethylamino)-1-propylamine followed by treatment with halohydrocarbons and showed excellent thermal stability and surface properties useful for various oilfield applications such as enhanced oil recovery.